Expression of the LYST and SLFN12L Genes in Peripheral Blood Leukocytes in Patients with Chronic Pulmonary Sarcoidosis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The expression of the LYST and SLFN12L genes in peripheral blood leukocytes (PBL) in patients with pulmonary sarcoidosis with a chronic course of the disease and in healthy people was studied in this work. Patients with chronic pulmonary sarcoidosis, on the second stage of the disease (20 people without therapy, average age of whom was 41.00 ± 12.56 years) and 25 healthy people (average age was 45.86 ± 2.13 years) were enrolled in this study. The level of gene expression was determined by real-time PCR. A significant decrease in the transcripts of the SLFN12L gene (p = 0.002) and a low content of mRNA of the LYST gene (p = 0.09) in the PBL of patients with pulmonary sarcoidosis compared to healthy people was established. Differential expression of LYST and SLFN12L may indicate the involvement of these genes in the pathogenesis of this disease, and it is possible they participate in the modulation of immune reactions during the development of inflammatory processes in pulmonary sarcoidosis.

全文:

受限制的访问

作者简介

I. Malysheva

Karelian Research Centre of the Russian Academy of Sciences

编辑信件的主要联系方式.
Email: i.e.malysheva@yandex.ru
俄罗斯联邦, Petrozavodsk, 185910

O. Balan

Karelian Research Centre of the Russian Academy of Sciences

Email: i.e.malysheva@yandex.ru
俄罗斯联邦, Petrozavodsk, 185910

E. Tikhonovich

Karelian Research Centre of the Russian Academy of Sciences; Baranov Republican Hospital

Email: i.e.malysheva@yandex.ru
俄罗斯联邦, Petrozavodsk, 185910; Petrozavodsk, 185019

参考

  1. Саркоидоз / под ред. А. А. Визеля. М.: Атмосфера, 2010. 30 с.
  2. Baughman R. P., Culver D. A., Judson M. A. A concise review of pulmonary sarcoidosis // Am. J. Respir. Crit. Care Med. 2011. V. 183. № 5. P. 573–581. doi: 10.1164/rccm.201006-0865CI
  3. Lynch J. P., Ma Y. L., Koss M. N., White E. S. Pulmonary sarcoidosis // Semin. Respir. Crit. Care Med. 2007. V. 28. № 31. P. 53–74. doi: 10.1055/s-2007-970333
  4. Patterson K. C., Chen E. S. The pathogenesis of pulmonary sarcoidosis and implications for treatment // CHEST. 2018. V. 153. № 6. P. 1432–1442. doi: 10.1111/j.1398-9995.2005.00778.x
  5. McDougal K., Fallin M., Moller D. et al. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis // J. Invest. Dermat. 2009. V. 129. № 8. P. 1921–1926. doi: 10.1038/jid.2008.456
  6. Terwiel M., van Moorsel C. H. M. Clinical epidemiology of familial sarcoidosis: A systematic literature review // Respir. Med. 2019. V. 149. P. 36–41.
  7. Hocˇevar K., Maver A., Kunej T., Peterlin B. Sarcoidosis related novel candidate genes identified by multi-omics integrative analyses // OMICS. 2018. V. 22. № 5. P. 322–331. doi: 10.1089/omi.2018.0027
  8. Konigsberg I. R., Lin N. W., Liao S. Y. et al. Multi-omic signatures of sarcoidosis and progression in bronchoalveolar lavage cells // bioRxiv. 2023. doi: 10.1101/2023.01.26.525601
  9. Ji X., Chang B., Naggert J. K., Nishida P. M. Lysosomal trafficking regulator // Adv. Exp. Med. Biol. 2016. V. 854. P. 745–750. doi: 10.1007/978-3-319-17121-0_99
  10. Lattao R., Rangone H., Llamazares S. et al. Mauve/LYST limits fusion of lysosome-related and promotes centrosomal recruitment of microtubule nucleating proteins // Dev. Cell. 2021. V. 56. № 7. P. 1000–1013. doi: 10.1016/j.devcel.2021.02.019
  11. Silva L. M., Brenchley L., Moutsopoulos N. M. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis // Immunol. Rev. 2019. V. 287. № 1. P. 226–235. doi: 10.1111/imr.12724
  12. Jo U., Pommier Y. S. Structural, molecular, and functional insights into Schlafen proteins // Exp. Mol. Med. 2022. V. 54. № 6. P. 730–738. doi: 10.1038/s12276-022-00794-0
  13. Puck A., Aigner R., Modak M. et al. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T-cells // Res. Immunol. 2015. V. 5. P. 23–32.
  14. Criado E., Sánchez M., Ramírez J., et al. Pulmonary sarcoidosis: Typical and atypical manifestations at high-resolution CT with pathologic correlation // RadioGraphics. 2010. V. 30(6). P. 1567–1586. doi: 10.1148/rg.306105512
  15. Pinto J., Dias V., Zoller H. et al. Hepcidin messenger RNA expression in human lymphocytes // Immunology. 2010. V. 130 № 2. P. 217–230. doi: 10.1111/j.1365-2567.2009.03226.x
  16. Zhang F., Sriram S. Identification and characterization of the interferon-β-mediated p53 signal pathway in human peripheral blood mononuclear cells // Immunology. 2009. V. 128. Pt. 2. P. e905–e918. doi: 10.1111/j.1365-2567.2009.03104.x
  17. Pang Y., Wu L., Tang C. et al. Autophagy-inflammation interplay during infection: Balancing pathogen clearance and host onflammation // Front. Pharmacol. 2022. V. 13. doi: 10.3389/fphar.2022.832750

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. The expression level of the genes SLFN12L (a), LYST (b), LC3B2 (c), p53 (d) and ATG5 (e) in the PBL of conditionally healthy donors (1) and patients with pulmonary sarcoidosis (2). The horizontal lines inside the rectangles are the median, • is the mean value.

下载 (61KB)
索引源数据

版权所有 © Russian Academy of Sciences, 2024